The primary aim of the current study was to explore the potential for the Kv3.1/3.2-positive modulator, AUT00206 to influence DA synthesis capacity, as measured by [18F]-FDOPA PET in patients with schizophrenia. This evidence concerns the gene KCNC1 and schizophrenia.